Free Answer to Counterclaim - District Court of Delaware - Delaware

Case 1:07-cv-00572-GMS

Document 82

Filed 01/07/2008

Page 1 of 8

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
) ) ) ) Plaintiffs, ) v. ) ) ) ACTAVIS SOUTH ATLANTIC LLC, ) AUROBINDO PHARMA LTD., ) AUROBINDO PHARMA USA INC., ) MYLAN PHARMACEUTICALS INC., PAR ) ) PHARMACEUTICAL, INC., RANBAXY ) INC., RANBAXY LABORATORIES ) LIMITED, SUN PHARMACEUTICAL ) INDUSTRIES, INC., SUN ) PHARMACEUTICAL INDUSTRIES LTD, ) TEVA PHARMACEUTICALS USA, INC., ) TORRENT PHARMA INC. and TORRENT ) ) PHARMACEUTICALS LIMITED, ) ) Defendants. )

SANOFI-AVENTIS and SANOFI-AVENTIS U.S. LLC,

C.A. No. 07-572 (GMS)

PLAINTIFFS' REPLY TO DEFENDANTS RANBAXY LABORATORIES LIMITED AND RANBAXY INC.'S COUNTERCLAIMS Plaintiffs sanofi-aventis and sanofi-aventis U.S. LLC ("sanofi-aventis U.S."), for their Reply to the numbered paragraphs of the Counterclaims of Defendants Ranbaxy Laboratories Limited and Ranbaxy Inc.'s (collectively "Ranbaxy"), hereby state as follows: 112. Admitted that Ranbaxy purports to state declaratory judgment counterclaims that arise pursuant to 28 U.S.C. §§ 2201 and 2202 and the Patent Laws of the United States. 113. Admitted, upon information and belief. 114. Admitted. 115. Admitted. 116. Admitted.

Case 1:07-cv-00572-GMS

Document 82

Filed 01/07/2008

Page 2 of 8

117. Admitted. 118. Plaintiffs do not contest venue in this Court for this Action. 119. Admitted. 120. Sanofi-aventis is without information to form a belief as to the truth or falsity of the allegations in Paragraph 120 of Ranbaxy's Counterclaims, and on that basis denies such allegations. 121. Admitted. 122. Denied. 123. The allegations of Paragraph 123 of Ranbaxy's Counterclaims set forth legal conclusions and characterizations to which no response from sanofi-aventis is required. To the extent a response is necessary, sanofi-aventis denies the allegations of Paragraph 123. 124. Plaintiffs restate and incorporate by reference their responses to the allegations contained in Paragraphs 112-123 as though set forth specifically herein. 125. Denied. 126. Plaintiffs restate and incorporate by reference their responses to the allegations contained in Paragraphs 112-123 as though set forth specifically herein. 127. Denied. Wherefore, Plaintiffs deny that Ranbaxy is entitled to any relief, either as prayed for in its Counterclaims or otherwise. Plaintiffs further deny each allegation contained in Ranbaxy's Counterclaims that was not specifically admitted, denied, or otherwise responded to in this Reply to Defendants Ranbaxy Laboratories Ltd. and Ranbaxy Inc.'s Counterclaims.

-2-

Case 1:07-cv-00572-GMS

Document 82

Filed 01/07/2008

Page 3 of 8

MORRIS, NICHOLS, ARSHT & TUNNELL LLP

/s/ James W. Parrett, Jr.
Jack B. Blumenfeld (#1014) Maryellen Noreika (#3208) James W. Parrett (#4292) 1201 North Market Street P.O. Box 1347 Wilmington, DE 19899-1347 (302) 658-9200 Attorneys for Plaintiffs sanofi-aventis and sanofi-aventis U.S. LLC

OF COUNSEL John Desmarais Gerald J. Flattmann, Jr. William T. Vuk KIRKLAND & ELLIS, LLP Citigroup Center 153 E. 53rd Street New York, NY 10022 (212) 446-4800 January 7, 2008
1376822

-3-

Case 1:07-cv-00572-GMS

Document 82

Filed 01/07/2008

Page 4 of 8

CERTIFICATE OF SERVICE I hereby certify that on January 7, 2008 I electronically filed the foregoing with the Clerk of the Court using CM/ECF, which will send notification of such filing to:. Mary B. Matterer
MORRIS JAMES LLP

Andre G. Bouchard, Esquire Dominick T. Gattuso, Esquire BOUCHARD, MARGULES & FRIEDLANDER, P.A. Francis J. Murphy, Esquire MURPHY & LANDON Richard L. Horwitz, Esquire David E. Moore, Esquire POTTER ANDERSON & CORROON LLP Frederick L. Cottrell, II, Esquire Jameson A.L. Tweedie, Esquire RICHARDS, LAYTON & FINGER, P.A. Josy W. Ingersoll, Esquire John W. Shaw, Esquire
YOUNG CONAWAY STARGATT & TAYLOR, LLP

Philip A. Rovner, Esquire POTTER ANDERSON & CORROON LLP I further certify that I caused to be served copies of the foregoing document on January 7, 2008 upon the following in the manner indicated: Mary B. Matterer, Esquire MORRIS JAMES LLP 500 Delaware Avenue Suite 1500 Wilmington, DE 19801 Counsel for Aurobindo Pharma LTD and Aurobindo Pharma USA Inc. VIA ELECTRONIC MAIL

Case 1:07-cv-00572-GMS

Document 82

Filed 01/07/2008

Page 5 of 8

Christine J. Siwik, Esquire Paul J. Molino, Esquire Deanne M. Mazzochi, Esquire RAKOCZY MOLINO MAZZOCHI SIWIK LLP 6 West Hubbard Street Suite 500 Chicago, IL 60610 Counsel for Aurobindo Pharma LTD and Aurobindo Pharma USA Inc. Richard L. Horwitz, Esquire David E. Moore, Esquire POTTER ANDERSON & CORROON LLP Hercules Plaza ­ 6th Floor 1313 North Market Street Wilmington, DE 19801 Counsel for Mylan Pharmaceuticals Inc. Timothy H. Kratz, Esquire Robert J. Waddell Jr., Esquire Robert L. Florence, Esquire MCGUIRE WOODS LLP 1170 Peachtree Street Suite 2100 Atlanta, GA 30309 Counsel for Mylan Pharmaceuticals Inc. Lynn E. Eccleston, Esquire MCGUIRE WOODS LLP 1750 Tysons Boulevard Suite 1800 McLean, VA 22102-4215 Counsel for Mylan Pharmaceuticals Inc. Francis J. Murphy, Esquire MURPHY & LANDON 1011 Centre Road Suite 210 Wilmington, DE 19805 Counsel for Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.

VIA ELECTRONIC MAIL

VIA ELECTRONIC MAIL

VIA ELECTRONIC MAIL

VIA ELECTRONIC MAIL

VIA ELECTRONIC MAIL

-2-

Case 1:07-cv-00572-GMS

Document 82

Filed 01/07/2008

Page 6 of 8

Keith D. Parr, Esquire Kevin M. Nelson, Esquire David B. Abramowitz, Esquire LOCKE LORD BISSELL & LIDDELL LLP 111 South Wacker Drive Chicago, IL 60606 Counsel for Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd. Robert B. Breisblatt, Esquire Steven E. Feldman, Esquire Sherry L. Rollo, Esquire WELSH & KATZ LTD. 120 S. Riverside Plaza 22nd Floor Chicago, IL 60606 Counsel for Sun Pharmaceutical Industries, Inc. and Sun Pharmaceuticals Industries, Ltd. Josy W. Ingersoll, Esquire John W. Shaw, Esquire YOUNG CONAWAY STARGATT & TAYLOR, LLP The Brandywine Building 1000 West Street 17th Floor Wilmington, DE 19801 Counsel for Teva Pharmaceuticals USA, Inc. Christopher J. Sorenson, Esquire MERCHANT & GOULD An Intellectual Property Law Firm 80 South 8th Street 3200 IDS Center Minneapolis, MN 55402 Counsel for Teva Pharmaceuticals USA, Inc. Andre G. Bouchard, Esquire Dominick T. Gattuso, Esquire BOUCHARD, MARGULES & FRIEDLANDER, P.A. 222 Delaware Avenue Suite 1400 Wilmington, DE 19801 Counsel for Actavis South Atlantic LLC and Par Pharmaceutical, Inc.

VIA ELECTRONIC MAIL

VIA ELECTRONIC MAIL

VIA ELECTRONIC MAIL

VIA ELECTRONIC MAIL

VIA ELECTRONIC MAIL

-3-

Case 1:07-cv-00572-GMS

Document 82

Filed 01/07/2008

Page 7 of 8

John Will Ongman, Esquire Sanjay B. Sitlani, Esquire AXINN, VELTROP & HARKRIDER LLP 1330 Connecticut Avenue, NW Washington, DC 20036 Counsel for Actavis South Atlantic LLC and Par Pharmaceutical, Inc. Chad A. Landmon, Esquire AXINN, VELTROP & HARKRIDER LLP 90 State House Square Hartford, CT 06103-3702 Counsel for Actavis South Atlantic LLC and Par Pharmaceutical, Inc. Frederick L. Cottrell, III, Esquire Jameson A.L. Tweedie, Esquire RICHARDS, LAYTON & FINGER, P.A. One Rodney Square 920 North King Street Wilmington, DE 19801 Counsel for Ranbaxy Inc. and Ranbaxy Laboratories Limited Darrell L. Olson, Esquire William R. Zimmerman, Esquire KNOBBE, MARTENS, OLSON & BEAR 2040 Main Street 14th Floor Irvine, CA 29614 Counsel for Ranbaxy Inc. and Ranbaxy Laboratories Limited Philip A. Rovner, Esquire POTTER ANDERSON & CORROON LLP Hercules Plaza 1313 North Market Street Wilmington, DE 19801 Counsel for Sun Pharmaceutical Industries, Inc. and Sun Pharmaceutical Industries Ltd.

VIA ELECTRONIC MAIL

VIA ELECTRONIC MAIL

VIA ELECTORNIC MAIL

VIA ELECTRONIC MAIL

VIA ELECTRONIC MAIL

-4-

Case 1:07-cv-00572-GMS

Document 82

Filed 01/07/2008

Page 8 of 8

Eric C. Cohen, Esquire Manotti L. Jenkins, Esquire KATTEN MUCHIN ROSENMAN LLP 525 West Monroe Street Chicago, IL 60661-3693 Counsel for Sun Pharmaceutical Industries, Inc. and Sun Pharmaceutical Industries Ltd.

VIA ELECTRONIC MAIL

/s/ James W. Parrett, Jr.
James W. Parrett, Jr. (#4292)

-5-